Supernus Pharmaceuticals, Inc (SUPN) insider trading
Every open-market stock purchase and sale by Supernus Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $16.6M over the last 12 months (13 sales). No open-market buys.
- Last insider buy: Jack A. Khattar (CEO), $190K, 7 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $16.6M (13 sales). Last close $48.27 on Aug 14, 2026.
Recent SUPN insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 12, 2026 | Jack A. Khattar (CEO) | Sold (not open market) | $589K |
| Aug 12, 2026 | Padmanabh P. Bhatt (C-suite exec) | Sold (not open market) | $53.9K |
| Aug 12, 2026 | Frank Mottola (CTO) | Sold (not open market) | $37.1K |
| Aug 12, 2026 | Timothy C Dec (CFO) | Sold (not open market) | $28.1K |
| Aug 12, 2026 | Jonathan Rubin (C-suite exec) | Sold (not open market) | $16.9K |
| Aug 12, 2026 | Frank Mottola (CTO) | Bought (not open market) | — |
| Aug 12, 2026 | Timothy C Dec (CFO) | Bought (not open market) | — |
| Aug 12, 2026 | Padmanabh P. Bhatt (C-suite exec) | Bought (not open market) | — |
| Aug 12, 2026 | Jack A. Khattar (CEO) | Bought (not open market) | — |
| Aug 12, 2026 | Jonathan Rubin (C-suite exec) | Bought (not open market) | — |
| Jul 29, 2026 | Jack A. Khattar (CEO) | Bought (not open market) | — |
| Jul 29, 2026 | Jonathan Rubin (C-suite exec) | Bought (not open market) | — |
| Jul 29, 2026 | Padmanabh P. Bhatt (C-suite exec) | Bought (not open market) | — |
| Jul 29, 2026 | Frank Mottola (CTO) | Bought (not open market) | — |
| Jul 29, 2026 | Timothy C Dec (CFO) | Bought (not open market) | — |
| Mar 18, 2026 | Padmanabh P. Bhatt (C-suite exec) | Sold | $339K |
| Mar 18, 2026 | Padmanabh P. Bhatt (C-suite exec) | Sold | $20.8K |
| Mar 18, 2026 | Padmanabh P. Bhatt (C-suite exec) | Bought (not open market) | — |
| Mar 17, 2026 | Padmanabh P. Bhatt (C-suite exec) | Sold | $1.4M |
| Mar 17, 2026 | Padmanabh P. Bhatt (C-suite exec) | Sold | $1.1M |
| Mar 17, 2026 | Padmanabh P. Bhatt (C-suite exec) | Bought (not open market) | — |
| Mar 17, 2026 | Padmanabh P. Bhatt (C-suite exec) | Bought (not open market) | — |
| Mar 17, 2026 | Padmanabh P. Bhatt (C-suite exec) | Bought (not open market) | — |
| Mar 16, 2026 | Padmanabh P. Bhatt (C-suite exec) | Sold | $1.7M |
| Mar 16, 2026 | Padmanabh P. Bhatt (C-suite exec) | Sold | $802K |
Who's trading SUPN
- Frank Mottola, VP: sold $1.1M (3 sales), last Aug 12, 2026
- Padmanabh P. Bhatt, C-suite exec: sold $5.4M (7 sales), last Aug 12, 2026
- Timothy C Dec, CFO: other filings, last Aug 12, 2026
- Jack A. Khattar, CEO: sold $6.8M (7 sales), last Aug 12, 2026
- Jonathan Rubin, C-suite exec: other filings, last Aug 12, 2026
- Frederick M. Hudson, Director: sold $272K (1 sale), last Mar 12, 2026
- William Todd Horich, VP: sold $484K (2 sales), last Mar 10, 2026
- Georges Gemayel, Director: sold $1M (2 sales), last Mar 6, 2026
- Carrolee Barlow, Director: other filings, last Feb 24, 2026
- Charles W Newhall III, Director: sold $1.3M (2 sales), last Feb 24, 2026
- Bethany Sensenig, Director: sold $228K (2 sales), last Feb 19, 2026
Get free alerts when an insider at Supernus Pharmaceuticals, Inc files a new trade →